Alnylam Pharmaceuticals (ALNY) Q4 2018 Earnings

7NovConfirmed
Q1 2018
Q2 2018
Q3 2018
Q4 2018
-2.43
-2.08
-1.74
-1.39

Details

Expected EPS
-2.07
Actual EPS
-2.43
Surprise EPS
-0.36
Surprise Percent
+17.39%

Description

Alnylam Pharmaceuticals (ALNY) has reported earnings of -2.43 per share for Q4 2018.

0 Comments

Share your thoughts